CRYSVITA 20 mg, solution injectable

Business Listing - September 04, 2021

CRYSVITA 20 mg, solution injectable

CRYSVITA 20 mg, solution injectable solution injectable sous-cutanée Autorisation active Procédure centralisée Commercialisée 2/19/2018 KYOWA KIRIN HOLDINGS (PAYS-BAS)

Tags & Categories

active solution injectable autorisation procédure commercialisée cutanée centralisée holdings kyowa crysvita

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business